SAN FRANCISCO and CAPE TOWN, South Africa, April 22, 2026 (GLOBE NEWSWIRE)-- Medicines360 and Pharma Dynamics have announced the availability of AVIBELA, South Africa’s first generic levonorgestrel 52 ...
SAN FRANCISCO and PARIS, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Medicines360, a global nonprofit pharmaceutical organization specializing in women’s health, and DKT WomanCare, a global marketing and ...
SAN FRANCISCO and LONDON and NAIROBI, Kenya, Aug. 2, 2021 /PRNewswire/ -- Medicines360, MSI Reproductive Choices (MSI) and Marie Stopes Kenya (MSK) today announced the launch of AVIBELA ...
SAN FRANCISCO and SAN DIEGO and WASHINGTON, May 7, 2018 /PRNewswire-USNewswire/ -- Medicines360, WCG, and Population Services International (PSI) today announced the launch of AVIBELA ...
(MENAFN- GlobeNewsWire - Nasdaq) SAN FRANCISCO and CAPE TOWN, South Africa, April 22, 2026 (GLOBE NEWSWIRE) -- Medicines360 and Pharma Dynamics have announced the availability of AVIBELA, South Africa ...
(MENAFN- GlobeNewsWire - Nasdaq) Medicines360 and DKT WomanCare are joining forces to increase availability and use of AVIBELA, an affordable, effective, long-acting hormonal IUD developed by ...
SAN FRANCISCO and PARIS, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Medicines360, a global nonprofit pharmaceutical organization specializing in women’s health, and DKT WomanCare, a global marketing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results